The Antidote - Autumn 2016
We are delighted to attach the Autumn 2016 edition of The Antidote, our Lifesciences sector bulletin.
In this edition, we look at:
- A recent report by the UK/EU Lifesciences Transition Programme’s steering group on the key areas for the UK to address as it negotiates an exit from the EU;
- The UK Government’s announcement of a Great Repeal Bill to end the supremacy of EU law and how this may affect key legislative areas for the sector;
- The CMA’s renewed focus on the Lifesciences industry;
- The agreed draft texts for the EU’s new Medical Devices Regulation (MDR) and In Vitro Diagnostics Medical Devices Regulation (IVDR).
If you would like to discuss any of these topics in more detail, please get in touch with Sarah Hanson or the authors of the articles.